Search Results 71-80 of 16362 for pharmacogenetics

  1. Research Opportunities - Curriculum - Mayo Clinic College of Medicine & Science

    Pharmacogenetics; Immunotherapy; Artificial intelligence in medicine. Clinical research. Mayo Clinic conducts hundreds of clinical trials for patients with both ...

  2. Genetic-guided testing for blood thinner drugs offers patients individualized treatment - Mayo Clinic

    The American Heart Association gives guidance on CYP2C19 genetic-guided testing for prescribing blood thinner drugs. A Mayo Clinic cardiologist chaired the ...

  3. A Study to Evaluate Patient Experiences with Pharmacogenomic-Based Individualized Medicine - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Genetic Testing Clinical Trials - Mayo Clinic Research

    Pharmacogenetic Testing in Children With Persistent Gastroesophageal Reflux Disease Rochester, MN. This study will use a 22 gene pharmacogenomics panel on 30 ...

  5. Treatment-resistant depression - Mayo Clinic

    Consider pharmacogenetic testing. These tests check for specific genes ... Currently, pharmacogenetics tests are not a sure way to show if a medication ...

  6. Laboratory Genetics - Laboratory Medicine and Pathology - Mayo Clinic

    Laboratory Genetics enhances clinical patient care through genetic disease study, genetic testing advances and emerging related technologies.

  7. Publications - Loralie J. Langman, Ph.D. - Mayo Clinic

    Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. ... Pharmacogenetic workup of ...

  8. Right Drug, Right Dose, Right Time – Using Genomic Data to Individualize Treatment - Mayo Clinic

    About this study. This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of ...

  9. Pharmacogenomics Education within Nurse Anesthesia Programs and Implications for the Anesthesia Provider - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... pharmacogenetics component of this study. Refusal to give consent for this component does not exclude a participant from participation in this clinical ...